Iparomlimab (QL1604) in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) unresectable or metastatic solid tumors: a pivotal, single-arm, multicenter, phase II trial
Feng Bi(Tianjin University of Traditional Chinese Medicine), Weijian Guo(Shanghai Medical College of Fudan University), Chuan Jin(Guangzhou Medical University), Baihui Zhang(Qilu Hospital of Shandong University), Yifu He(Anhui Provincial Hospital), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Kehe Chen(The People's Hospital of Guangxi Zhuang Autonomous Region), Zuoxing Niu(Shandong Tumor Hospital), Lei Han(Affiliated Hospital of Jining Medical University), Wenlei Feng(Qilu Hospital of Shandong University), Xiaoyan Kang(Qilu Hospital of Shandong University), Dajun Yu(Jinan University), Meili Sun(Jinan Central Hospital), Lingyan Li(Qilu Hospital of Shandong University), Wei Li(Xiamen University), Teng Wang(Duke University), Wei Shen(University of Utah), Zhongtao Zhang(Capital Medical University), Jian Dong(Anyang Hospital of Traditional Chinese Medicine), Hangyu Zhang(Zhejiang University), Weiguo Hu(Ruijin Hospital), Ruixing Zhang(Hebei Medical University), Zhiwu Wang(Tangshan People's Hospital), Xiaofen Li(Wuhan University), Qunyi Guo(Wenzhou Medical University), Miao Wu(Second People’s Hospital of Yibin), Li Zeng(Xi'an Jiaotong University), Xianli Yin(Central South University), Keming Wang(Second Affiliated Hospital of Nanjing Medical University), Xizhi Zhang(People's Hospital of Kaizhou District), Wenhui Yang(Shanxi Medical University), Xin Wang(Capital Medical University), Liangming Zhang(Sun Yat-sen University)
Cited by 8
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
|Molecular Cancer|2021|461